Alamar Biosciences, Inc.

Healthcare · Medical Instruments & Supplies · United States

Last price 30.6 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.12B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, translational research and ultimately, and diagnosti...